Radiation dose estimation using preclinical imaging with I124-metaiodobenzylguanidine (MIBG) PET

Radiation Dosimetry, Pharmacokinetics, and Safety of Ultratrace™ Iobenguane I-131 in Patients with Malignant Pheochromocytoma/Paraganglioma or Metastatic Carcinoid

(2009) R. Edward Coleman et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Phase II Study of High-Dose [131I]Metaiodobenzylguanidine Therapy for Patients With Metastatic Pheochromocytoma and Paraganglioma

(2009) Sara Gonias et al.   JOURNAL OF CLINICAL ONCOLOGY

124I PET-Based 3D-RD Dosimetry for a Pediatric Thyroid Cancer Patient: Real-Time Treatment Planning and Methodologic Comparison

(2009) R. F. Hobbs et al.   JOURNAL OF NUCLEAR MEDICINE

Human Dosimetry of Carbon-11 Labeled N-butan-2-yl-1-(2-chlorophenyl)-N-methylisoquinoline-3-carboxamide Extrapolated from Whole-body Distribution Kinetics and Radiometabolism in Rats

(2009) Pauliina Luoto et al.   MOLECULAR IMAGING AND BIOLOGY

Uptake of mIBG and catecholamines in noradrenaline- and organic cation transporter-expressing cells: potential use of corticosterone for a preferred uptake in neuroblastoma- and pheochromocytoma cells

(2009) Melanie Bayer et al.   NUCLEAR MEDICINE AND BIOLOGY

The diagnostic value of 124I-PET in patients with differentiated thyroid cancer

(2008) Ha T. T. Phan et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Optimized 124I PET Dosimetry Protocol for Radioiodine Therapy of Differentiated Thyroid Cancer

(2008) W. Jentzen et al.   JOURNAL OF NUCLEAR MEDICINE